Search - tctmd.com

Displaying 341 - 360 of 665

Sort: Relevancy | Date

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Daily News

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Michael O'Riordan

June 22, 2017

Presentation

Trends and Outcomes of Off-Label Use of TAVR in 23,847 Patients in TVT Registry

June 22, 2017

News Daily News

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Caitlin E. Cox

June 21, 2017

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Industry News

iVascular & Braile partner to develop structural heart solutions

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Will the Heart Team Survive the Modern Era of Minimalist TAVR?

Presenter: Martin B. Leon, Hendrik Treede, Wilson Y. Szeto

June 16, 2017

Presentation TVT 2017

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

Presenter: Martin B. Leon, Hendrik Treede

June 16, 2017

Presentation TVT 2017

Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials

Presenter: Martin B. Leon, Hendrik Treede, Philippe Pibarot

June 16, 2017

Presentation TVT 2017

The Latest in TAVR Adjunctive Pharmacotherapy: The Case for Routine vs Selective Anticoagulant Therapy

Presenter: Martin B. Leon, Hendrik Treede, George D. Dangas

June 16, 2017

Presentation TVT 2017

An Imaging Perspective of Leaflet Thickening on MDCT: Lessons Learned and Next Steps

Presenter: Martin B. Leon, Hendrik Treede, Philipp Blanke

June 16, 2017

Presentation TVT 2017

Subclinical Leaflet Thrombosis in Surgical and Transcatheter Bioprosthetic Aortic Valves Cautionary Findings and Clinical Implications

Presenter: Martin B. Leon, Hendrik Treede, Raj Makkar

June 16, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

Presentation TVT 2017

Simultaneous Transcatheter Transfemoral Aortic and Transeptal Mitral Valve Replacement Using Edward SAPIEN S3

Presenter: Horst Sievert, Robert L. Smith, Zaher Fanari, MD

June 16, 2017

Presentation TVT 2017

Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future?

Presenter: David J. Cohen, Jeffrey J. Popma, Robert O. Bonow

June 16, 2017

Presentation TVT 2017

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Philippe Généreux

June 16, 2017

Presentation TVT 2017

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: David J. Cohen, Jeffrey J. Popma, Nicolas M. Van Mieghem

June 16, 2017

Advertisement

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Trends and Outcomes of Off-Label Use of TAVR in 23,847 Patients in TVT Registry

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Valve Leaflet Thrombosis: Treat It or Leave It Be?

iVascular & Braile partner to develop structural heart solutions

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Will the Heart Team Survive the Modern Era of Minimalist TAVR?

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

Hemodynamic Trends on Serial Echocardiograms After TAVR: Comprehensive 5-Year Analyses From the PARTNER 1 Trials

The Latest in TAVR Adjunctive Pharmacotherapy: The Case for Routine vs Selective Anticoagulant Therapy

An Imaging Perspective of Leaflet Thickening on MDCT: Lessons Learned and Next Steps

Subclinical Leaflet Thrombosis in Surgical and Transcatheter Bioprosthetic Aortic Valves Cautionary Findings and Clinical Implications

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Simultaneous Transcatheter Transfemoral Aortic and Transeptal Mitral Valve Replacement Using Edward SAPIEN S3

Is the Current Practice of Watchful Waiting in Severe AS a Viable Strategy in the Future?

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content